Varex Imaging (NASDAQ:VREX) Issues Earnings Results

Varex Imaging (NASDAQ:VREX) posted its quarterly earnings data on Thursday. The company reported $0.16 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.23 by ($0.07), Briefing.com reports. The company had revenue of $206.20 million during the quarter, compared to the consensus estimate of $205.15 million. Varex Imaging had a net margin of 5.08% and a return on equity of 9.21%. Varex Imaging’s revenue for the quarter was down 9.6% on a year-over-year basis. During the same period in the previous year, the business earned $0.26 earnings per share. Varex Imaging updated its Q3 guidance to $0.05 to $0.25 EPS.

Varex Imaging Trading Down 5.1 %

VREX traded down $0.84 during trading hours on Friday, reaching $15.59. 1,030,491 shares of the company’s stock traded hands, compared to its average volume of 327,836. The company has a quick ratio of 2.37, a current ratio of 4.30 and a debt-to-equity ratio of 0.76. The firm has a 50-day moving average price of $17.32 and a 200 day moving average price of $18.49. Varex Imaging has a 52-week low of $14.56 and a 52-week high of $23.90. The firm has a market capitalization of $632.95 million, a PE ratio of 16.24, a PEG ratio of 2.39 and a beta of 0.72.

Wall Street Analysts Forecast Growth

Separately, TheStreet downgraded Varex Imaging from a “b-” rating to a “c” rating in a research report on Tuesday, February 6th.

About Varex Imaging

Varex Imaging Corporation designs, manufactures, and sells X-ray imaging components. The company operates through two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components, comprising X-ray tubes, digital detectors and accessories, ionization chambers, high voltage connectors, image-processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and heat exchangers.